Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancer.

Hata A, Harada D, Okuda C, Kaji R, Masuda Y, Takechi Y, Kozuki T, Nogami N, Katakami N.

Oncotarget. 2018 Jun 12;9(45):27789-27796. doi: 10.18632/oncotarget.25578. eCollection 2018 Jun 12.

2.

[Intervention for COPD Exacerbation - How To Prevent and Treat COPD Exacerbation ?]

Takechi Y.

Gan To Kagaku Ryoho. 2016 Dec;43(Suppl 1):61-63. Japanese.

PMID:
28028282
3.

Kinetic and thermodynamic analyses of spontaneous exchange between high-density lipoprotein-bound and lipid-free apolipoprotein A-I.

Handa D, Kimura H, Oka T, Takechi Y, Okuhira K, Phillips MC, Saito H.

Biochemistry. 2015 Feb 3;54(4):1123-31. doi: 10.1021/bi501345j. Epub 2015 Jan 16.

PMID:
25564321
4.
5.

[Problems of collaboration between community and hospital pharmacists for cancer chemotherapy and proposed corrective measures: KJ method based identification and planning workshop].

Satoh H, Miki A, Maejima K, Iizuka K, Yamaga S, Sakashita K, Takano Y, Takahashi Y, Tajiri K, Takechi Y, Shimada M, Suzuki M, Sawada Y.

Yakugaku Zasshi. 2014;134(4):563-74. Japanese.

6.

Thermotropic phase behavior of hydrogenated soybean phosphatidylcholine-cholesterol binary liposome membrane.

Kitayama H, Takechi Y, Tamai N, Matsuki H, Yomota C, Saito H.

Chem Pharm Bull (Tokyo). 2014;62(1):58-63.

7.

The roles of C-terminal helices of human apolipoprotein A-I in formation of high-density lipoprotein particles.

Nagao K, Hata M, Tanaka K, Takechi Y, Nguyen D, Dhanasekaran P, Lund-Katz S, Phillips MC, Saito H.

Biochim Biophys Acta. 2014 Jan;1841(1):80-7. doi: 10.1016/j.bbalip.2013.10.005. Epub 2013 Oct 9.

8.

Impairment of spinal motor neurons in spinocerebellar ataxia type 1-knock-in mice.

Takechi Y, Mieda T, Iizuka A, Toya S, Suto N, Takagishi K, Nakazato Y, Nakamura K, Hirai H.

Neurosci Lett. 2013 Feb 22;535:67-72. doi: 10.1016/j.neulet.2012.12.057. Epub 2013 Jan 14.

PMID:
23328439
9.

Effect of a reduction of the atlanto-axial angle on the cranio-cervical and subaxial angles following atlanto-axial arthrodesis in rheumatoid arthritis.

Iizuka H, Iizuka Y, Kobayashi R, Takechi Y, Nishinome M, Ara T, Sorimachi Y, Nakajima T, Takagishi K.

Eur Spine J. 2013 May;22(5):1137-41. doi: 10.1007/s00586-012-2628-x. Epub 2013 Jan 1.

10.

Detection and in situ switching of unreversed interfacial antiferromagnetic spins in a perpendicular-exchange-biased system.

Shiratsuchi Y, Noutomi H, Oikawa H, Nakamura T, Suzuki M, Fujita T, Arakawa K, Takechi Y, Mori H, Kinoshita T, Yamamoto M, Nakatani R.

Phys Rev Lett. 2012 Aug 17;109(7):077202. Epub 2012 Aug 16.

PMID:
23006398
11.

Characteristics of idiopathic atlanto-axial subluxation: a comparative radiographic study in patients with an idiopathic etiology and those with rheumatoid arthritis.

Iizuka H, Iizuka Y, Kobayashi R, Takechi Y, Nishinome M, Ara T, Sorimachi Y, Nakajima T, Takagishi K.

Eur Spine J. 2013 Jan;22(1):54-9. doi: 10.1007/s00586-012-2466-x. Epub 2012 Aug 10.

13.

Comparative study on the interaction of cell-penetrating polycationic polymers with lipid membranes.

Takechi Y, Tanaka H, Kitayama H, Yoshii H, Tanaka M, Saito H.

Chem Phys Lipids. 2012 Jan;165(1):51-8. doi: 10.1016/j.chemphyslip.2011.11.002. Epub 2011 Nov 12.

PMID:
22108318
14.

Physicochemical mechanism for the enhanced ability of lipid membrane penetration of polyarginine.

Takechi Y, Yoshii H, Tanaka M, Kawakami T, Aimoto S, Saito H.

Langmuir. 2011 Jun 7;27(11):7099-107. doi: 10.1021/la200917y. Epub 2011 Apr 28.

PMID:
21526829
15.

Atlanto-axial subluxation after pyogenic spondylitis of the atlanto-occipital joint.

Tsunoda K, Iizuka H, Sorimachi Y, Ara T, Nishinome M, Takechi Y, Takagishi K.

Eur Spine J. 2011 Jul;20 Suppl 2:S253-7. doi: 10.1007/s00586-010-1651-z. Epub 2010 Dec 8.

16.

Comparison of antiemetic efficacy between single and repeat treatment with dexamethasone in patients receiving carboplatin-based combination chemotherapy.

Kawazoe H, Motoki Y, Takechi Y, Shishino Y, Ido K, Suemaru K, Araki H.

Methods Find Exp Clin Pharmacol. 2010 Sep;32(7):499-505. doi: 10.1358/mf.2010.32.7.1501438.

PMID:
21069101
17.

Influence of N-terminal helix bundle stability on the lipid-binding properties of human apolipoprotein A-I.

Tanaka M, Dhanasekaran P, Nguyen D, Nickel M, Takechi Y, Lund-Katz S, Phillips MC, Saito H.

Biochim Biophys Acta. 2011 Jan;1811(1):25-30. doi: 10.1016/j.bbalip.2010.10.003. Epub 2010 Oct 30.

18.

Non-traumatic posterior atlanto-occipital joint dislocation.

Takechi Y, Iizuka H, Sorimachi Y, Ara T, Nishinome M, Takagishi K.

Eur Spine J. 2011 Jul;20 Suppl 2:S172-5. doi: 10.1007/s00586-010-1480-0. Epub 2010 Jun 13.

19.

[Domiciliary non-invasive positive pressure ventilation (NPPV) care].

Takechi Y, Endo N, Fuse M, Maruyama Y, Matsunaga A.

Gan To Kagaku Ryoho. 2009 Dec;36 Suppl 1:110-2. Japanese.

PMID:
20443419
20.

Multiple subcutaneous inflammation, osteolysis, and polyarthritis.

Takechi Y, Shinozaki T, Fukuda T, Asami K, Yanagawa T, Takagishi K.

Skeletal Radiol. 2010 Jun;39(6):601-2. doi: 10.1007/s00256-010-0878-4. No abstract available.

PMID:
20177674
21.

Multiple subcutaneous inflammation, osteolysis, and polyarthritis.

Takechi Y, Shinozaki T, Fukuda T, Asami K, Yanagawa T, Takagishi K.

Skeletal Radiol. 2010 Jun;39(6):581-2, 601-2. doi: 10.1007/s00256-010-0876-6. Epub 2010 Feb 20. No abstract available.

PMID:
20174794
22.

The relationship between the reproducibility of holmium laser enucleation of the prostate and prostate size over the learning curve.

Haraguchi T, Takenaka A, Yamazaki T, Nakano Y, Miyake H, Tanaka K, Kuwayama M, Takechi Y, Fujisawa M.

Prostate Cancer Prostatic Dis. 2009;12(3):281-4. doi: 10.1038/pcan.2009.16. Epub 2009 Jul 7.

PMID:
19581921
23.

Laparoscopic adrenalectomy: troublesome cases.

Kawabata G, Shimogaki H, Yamanaka K, Matsushita K, Takechi Y.

Int J Urol. 2009 May;16(5):431. doi: 10.1111/j.1442-2042.2009.02288.x.

24.

Convenient one-pot synthesis of 2-oxazolines from carboxylic acids.

Hioki K, Takechi Y, Kimura N, Tanaka H, Kunishima M.

Chem Pharm Bull (Tokyo). 2008 Dec;56(12):1735-7.

25.

Hemophagocytic lymphohistiocytosis associated with uncontrolled inflammatory cytokinemia and chemokinemia was caused by systemic anaplastic large cell lymphoma: a case report and review of the literature.

Shimada A, Kato M, Tamura K, Hirato J, Kanegane H, Takechi Y, Park MJ, Sotomatsu M, Hatakeyama S, Hayashi Y.

J Pediatr Hematol Oncol. 2008 Oct;30(10):785-7. doi: 10.1097/MPH.0b013e318180bb33. Review. No abstract available.

PMID:
19011482
26.

[Hemorrhagic radiation cystitis: a transurethral treatment with formalin-soaked pledgets].

Haraguchi T, Yamazaki T, Takechi Y.

Hinyokika Kiyo. 2007 Aug;53(8):585-7; dscussion 587. Japanese.

27.
28.

Prognostic significance of the tumor volume in radical prostatectomy specimens after neoadjuvant hormonal therapy.

Miyake H, Sakai I, Harada K, Takechi Y, Hara I, Eto H.

Urol Int. 2005;74(1):27-31.

PMID:
15711105
29.

[A case of ectopic ureterocele in a male adult found during examination of a traumatic injury].

Sakamoto Y, Hyoudou Y, Okamoto M, Yamada Y, Takechi Y.

Hinyokika Kiyo. 2004 Apr;50(4):245-8. Review. Japanese.

30.

Alpha-fetoprotein-producing esophageal carcinoma: a case report.

Kawai H, Sekine S, Sanada T, Andoh T, Takechi Y, Okada S.

Anticancer Res. 2003 Sep-Oct;23(5A):3837-40.

PMID:
14666685
31.

[A life saving case of Vibrio vulnificus (septic type)].

Yagi H, Takechi Y, Hiraki S, Yamaguchi A, Yoshizato M, Furuyama M.

Kansenshogaku Zasshi. 2003 Mar;77(3):167-73. Japanese.

PMID:
12708010
32.

Increased urinary 8-hydroxy-2'-deoxyguanosine excretion after ileal neobladder replacement.

Miyake H, Eto H, Takechi Y, Kamidono S, Hara I.

BJU Int. 2003 May;91(7):657-60.

33.

The significance of prostate-specific antigen alpha-1-antichymotrypsin complex and its indices for the detection of prostate cancer.

Yamanaka K, Yamada Y, Kobayashi Y, Ueno K, Takechi Y, Hasegawa E, Chikahira Y.

Hinyokika Kiyo. 2003 Jan;49(1):5-10.

34.

Clinical outcome of conservative therapy for stage T1, grade 3 transitional cell carcinoma of the bladder.

Hara I, Miyake H, Takechi Y, Eto H, Gotoh A, Fujisawa M, Okada H, Arakawa S, Kamidono S; Kobe Urogenital Tumor Study Group.

Int J Urol. 2003 Jan;10(1):19-24.

35.

Neoadjuvant androgen withdrawal prior to external radiotherapy for locally advanced adenocarcinoma of the prostate.

Hara I, Miyake H, Yamada Y, Takechi Y, Hara S, Gotoh A, Fujisawa M, Okada H, Arakawa S, Soejima T, Sugimura K, Kamidono S.

Int J Urol. 2002 Jun;9(6):322-8; discussion 328.

36.

Nephrostomy tract tumor seeding following percutaneous manipulation of a renal pelvic carcinoma.

Yamada Y, Kobayashi Y, Yao A, Yamanaka K, Takechi Y, Umezu K.

Hinyokika Kiyo. 2002 Jul;48(7):415-8.

37.

Increased serum carcinoembryonic antigen level in patients undergoing colon neobladder replacement compared with ileal neobladder replacement.

Hara I, Miyake H, Hara S, Takechi Y, Eto H, Fujisawa M, Okada H, Arakawa S, Kamidono S.

Urology. 2002 Aug;60(2):363-7.

PMID:
12137854
38.

Predicting the extent of prostate cancer using a combination of serum prostate-specific antigen-alpha(1)-antichymotrypsin complex and systematic biopsy.

Miyake H, Hara S, Yamanaka N, Ono Y, Eto H, Yamada Y, Takechi Y, Arakawa S, Kamidono S, Hara I.

Urol Int. 2002;68(4):232-6.

PMID:
12053023
39.

Significance of prostate-specific antigen--alpha(1)-antichymotrypsin complex for diagnosis and staging of prostate cancer.

Hara I, Miyake H, Hara S, Yamada Y, Takechi Y, Fujisawa M, Okada H, Arakawa S, Kamidono S.

Jpn J Clin Oncol. 2001 Oct;31(10):506-9.

PMID:
11696621
40.

Value of the serum prostate-specific antigen-alpha 1-antichymotrypsin complex and its density as a predictor for the extent of prostate cancer.

Hara I, Miyake H, Hara S, Yamanaka N, Ono Y, Eto H, Takechi Y, Arakawa S, Kamidono S.

BJU Int. 2001 Jul;88(1):53-7.

41.

Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70.

Moroi Y, Mayhew M, Trcka J, Hoe MH, Takechi Y, Hartl FU, Rothman JE, Houghton AN.

Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3485-90.

42.

Clinical outcome of high-dose chemotherapy combined with peripheral blood stem cell transplantation for male germ cell tumors.

Hara I, Yamada Y, Miyake H, Nomi M, Hara S, Yamanaka K, Takechi Y, Oka Y, Nakamura I, Gotoh A, Gohji K, Arakawa S, Kamidono S.

Anticancer Drugs. 1999 Sep;10(8):711-8.

PMID:
10573203
43.

Priming for T-cell-mediated rejection of established tumors by cutaneous DNA immunization.

Ross HM, Weber LW, Wang S, Piskun G, Dyall R, Song P, Takechi Y, Nikolić-Zugić J, Houghton AN, Lewis JJ.

Clin Cancer Res. 1997 Dec;3(12 Pt 1):2191-6.

44.
45.

Clinical study of renal cell carcinoma with brain metastasis.

Yamanaka K, Gohji K, Hara I, Gotoh A, Takechi Y, Yamada Y, Taguchi I, Tamada H, Okada H, Arakawa S, Kamidono S.

Int J Urol. 1998 Mar;5(2):124-8.

46.

Fc receptors are required in passive and active immunity to melanoma.

Clynes R, Takechi Y, Moroi Y, Houghton A, Ravetch JV.

Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):652-6.

47.

Sorting and secretion of a melanosome membrane protein, gp75/TRP1.

Xu Y, Setaluri V, Takechi Y, Houghton AN.

J Invest Dermatol. 1997 Dec;109(6):788-95.

48.

Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity.

Naftzger C, Takechi Y, Kohda H, Hara I, Vijayasaradhi S, Houghton AN.

Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14809-14.

49.

A melanosomal membrane protein is a cell surface target for melanoma therapy.

Takechi Y, Hara I, Naftzger C, Xu Y, Houghton AN.

Clin Cancer Res. 1996 Nov;2(11):1837-42.

50.

The significance of E-cadherin in transitional-cell carcinoma of the human urinary bladder.

Fujisawa M, Miyazaki J, Takechi Y, Arakawa S, Kamidono S.

World J Urol. 1996;14 Suppl 1:S12-5.

PMID:
8738404

Supplemental Content

Loading ...
Support Center